WHO trial finds no benefit of 4 drugs for hospital COVID patients

Must Read
Dec 03, 2020

Neither remdesivir, hydroxychloroquine, lopinavir, nor interferon-beta-1a—prevented death or other serious outcomes. 

Mary Van Beusekom | News Writer | CIDRAP News

Dec 03, 2020
Neither remdesivir, hydroxychloroquine, lopinavir, nor interferon-beta-1a—prevented death or other serious outcomes. Read More

- Advertisement -spot_img

Leave a reply

Please enter your comment!
Please enter your name here

- Advertisement -spot_img
Latest News
- Advertisement -spot_img

More Articles Like This

- Advertisement -spot_img